Expanded Options for Advanced Ovarian Cancer

Maurie Markman, MD


July 07, 2020

Because there is no effective screening method, ovarian cancer is typically in advanced stages at diagnosis.

In most women, aggressive treatment results in complete clinical remission. The majority of patients, however, eventually experience disease progression and die from the disease.

Dr Maurie Markman reports on recent trials that expand the options for delaying disease progression in advanced ovarian cancer, and discusses selection of frontline therapy.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.